Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TSR3 ribosome maturation factor (TSR3) is a highly conserved eukaryotic enzyme required for the final maturation steps of 18S rRNA in the cytoplasmic phase of small ribosomal subunit (40S) biogenesis[1][3]. It functions as an aminocarboxypropyltransferase, utilizing S-adenosylmethionine (SAM) as a donor to install a universally conserved chemical modification—N1-methyl-N3-aminocarboxypropyl-pseudouridine (m^1acp^3Ψ)—at a specific site near the P-site of the 18S rRNA[1][3]. This modification is crucial for proper ribosome assembly and ensures the release of fully mature, functionally competent ribosomal subunits[1]. TSR3’s modification activity temporally coordinates the dissociation and binding of other ribosome assembly factors (notably Rio2 and Rio1 kinases), serving as a checkpoint for quality control in ribosome maturation[1]. Loss or inactivation of TSR3 leads to accumulation of immature rRNA precursors and defective ribosomes, affecting protein synthesis and overall cell growth[1][3]. The enzyme is homologous to the SPOUT-class RNA methyltransferases but uniquely transfers an aminocarboxypropyl group rather than a methyl group due to unique features in its SAM binding site[3]. Currently, there are no known drugs that target TSR3, and it is primarily studied as a fundamental factor for ribosome assembly rather than as a therapeutic target.
Not therapeutically targeted; mechanism is transfer of an aminocarboxypropyl group (from S-adenosylmethionine donor) to pseudouridine in 18S rRNA during ribosome assembly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TSR3 ribosome maturation factor (TSR3).